Relmada Therapeutics Inc

The current institutional shareholding score of Relmada Therapeutics Inc is 5.00, ranking 133 out of 388 in the Biotechnology & Medical Research industry. The latest institutional shareholding proportion is 56.47%, representing a quarter-over-quarter increase of 184.86%. The largest institutional shareholder is Steven Cohen, holding a total of 483.47K shares, representing 0.48% of shares outstanding, with 0.27% decrease in holdings.